SCHEMBL5873170

SCHEMBL5873170

C=CC(C(=O)c1cccs1)C(=O)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2D6 P10635 1/20 0.47
TSHR P16473 1/20 0.47
CES2 O00748 2/20 0.45
CES1 P23141 2/20 0.45
KEAP1 Q14145 1/20 0.45
DAO P14920 1/20 0.42
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
HDAC1 Q13547 1/20 0.40
CTNNB1 P35222 1/20 0.39
WNT3A P56704 1/20 0.39
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1681118 0.80 TSHR (0.51) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL6135938 0.80 CYP2C19 (0.46) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL28376224 0.79 TSHR (0.50) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL5873224 0.78 TSHR (0.49) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL3249145 0.78 CYP2C9 (0.52) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL10628291 0.76 TSHR (0.48) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL2802204 0.75 TSHR (0.50) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL4581429 0.74 CYP2C9 (0.46) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL27427456 0.74 CYP2C9 (0.49) CYP2C19CYP2C9CYP2D6TSHRCES2
SCHEMBL9237982 0.73 CES2 (0.50) CYP2C19CYP2C9CYP2D6TSHRCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067702-B2 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY (US) 2006-06-27 US disclosed
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones VRK1, VRK2, DEK CYP2C19 778/4885CYP2C9 1593/4885CYP2D6 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.